Identification of human cancers deficient in antigen processing

doi:10.1084/jem.177.2.265

This Article

	Full Text (PDF, 1004K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Restifo, N. P.
	Articles by Bennink, J. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Restifo, N. P.
	Articles by Bennink, J. R.


Social Bookmarking

	What's this?

ARTICLES

Identification of human cancers deficient in antigen processing

NP Restifo, F Esquivel, Y Kawakami, JW Yewdell, JJ Mule, SA Rosenberg and JR Bennink
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Intracellular antigens must be processed before presentation to CD8+ T cells by major histocompatibility complex (MHC) class I molecules. Using a recombinant vaccinia virus (Vac) to transiently express the Kd molecule, we studied the antigen processing efficiency of 26 different human tumor lines. Three cell lines, all human small cell lung carcinoma, consistently failed to process endogenously synthesized proteins for presentation to Kd-restricted, Vac-specific T cells. Pulse- chase experiments showed that MHC class I molecules were not transported by these cell lines from the endoplasmic reticulum to the cell surface. This finding suggested that peptides were not available for binding to nascent MHC molecules in the endoplasmic reticulum. Northern blot analysis of these cells revealed low to nondetectable levels of mRNAs for MHC-encoded proteasome components LMP-7 and LMP-2, as well as the putative peptide transporters TAP-1 and TAP-2. Treatment of cells with interferon gamma enhanced expression of these mRNAs and reversed the observed functional and biochemical deficits. Our findings suggest that downregulation of antigen processing may be one of the strategies used by tumors to escape immune surveillance. Potential therapeutic applications of these findings include enhancing antigen processing at the level of the transcription of MHC-encoded proteasome and transporter genes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Reid, G. S.D., Shan, X., Coughlin, C. M., Lassoued, W., Pawel, B. R., Wexler, L. H., Thiele, C. J., Tsokos, M., Pinkus, J. L., Pinkus, G. S., Grupp, S. A., Vonderheide, R. H. (2009). Interferon-{gamma}-Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo. Clin. Cancer Res. 15: 6602-6608 [Abstract] [Full Text]
Horkheimer, I., Quigley, M., Zhu, J., Huang, X., Chao, N. J., Yang, Y. (2009). Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation. Blood 113: 5330-5339 [Abstract] [Full Text]
Eriksson, F., Tsagozis, P., Lundberg, K., Parsa, R., Mangsbo, S. M., Persson, M. A. A., Harris, R. A., Pisa, P. (2009). Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages. J. Immunol. 182: 3105-3111 [Abstract] [Full Text]
Emtage, P. C.R., Lo, A. S.Y., Gomes, E. M., Liu, D. L., Gonzalo-Daganzo, R. M., Junghans, R. P. (2008). Second-Generation Anti-Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity In vivo: A Preclinical Evaluation. Clin. Cancer Res. 14: 8112-8122 [Abstract] [Full Text]
Palmer, D. C., Chan, C.-C., Gattinoni, L., Wrzesinski, C., Paulos, C. M., Hinrichs, C. S., Powell, D. J. Jr., Klebanoff, C. A., Finkelstein, S. E., Fariss, R. N., Yu, Z., Nussenblatt, R. B., Rosenberg, S. A., Restifo, N. P. (2008). From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc. Natl. Acad. Sci. USA 105: 8061-8066 [Abstract] [Full Text]
Janicki, C. N., Jenkinson, S. R., Williams, N. A., Morgan, D. J. (2008). Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration. Cancer Res. 68: 2993-3000 [Abstract] [Full Text]
Paulos, C. M., Kaiser, A., Wrzesinski, C., Hinrichs, C. S., Cassard, L., Boni, A., Muranski, P., Sanchez-Perez, L., Palmer, D. C., Yu, Z., Antony, P. A., Gattinoni, L., Rosenberg, S. A., Restifo, N. P. (2007). Toll-like Receptors in Tumor Immunotherapy. Clin. Cancer Res. 13: 5280-5289 [Abstract] [Full Text]
Assarsson, E., Sidney, J., Oseroff, C., Pasquetto, V., Bui, H.-H., Frahm, N., Brander, C., Peters, B., Grey, H., Sette, A. (2007). A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection. J. Immunol. 178: 7890-7901 [Abstract] [Full Text]
Hargadon, K. M., Brinkman, C. C., Sheasley-O'Neill, S. L., Nichols, L. A., Bullock, T. N. J., Engelhard, V. H. (2006). Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes. J. Immunol. 177: 6081-6090 [Abstract] [Full Text]
Yang, S.-C., Batra, R. K., Hillinger, S., Reckamp, K. L., Strieter, R. M., Dubinett, S. M., Sharma, S. (2006). Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma.. Cancer Res. 66: 3205-3213 [Abstract] [Full Text]
Guo, Z. S., Hong, J. A., Irvine, K. R., Chen, G. A., Spiess, P. J., Liu, Y., Zeng, G., Wunderlich, J. R., Nguyen, D. M., Restifo, N. P., Schrump, D. S. (2006). De novo Induction of a Cancer/Testis Antigen by 5-Aza-2'-Deoxycytidine Augments Adoptive Immunotherapy in a Murine Tumor Model. Cancer Res. 66: 1105-1113 [Abstract] [Full Text]
Hong, J. A., Kang, Y., Abdullaev, Z., Flanagan, P. T., Pack, S. D., Fischette, M. R., Adnani, M. T., Loukinov, D. I., Vatolin, S., Risinger, J. I., Custer, M., Chen, G. A., Zhao, M., Nguyen, D. M., Barrett, J. C., Lobanenkov, V. V., Schrump, D. S. (2005). Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells. Cancer Res. 65: 7763-7774 [Abstract] [Full Text]
Setiadi, A. F., David, M. D., Chen, S. S., Hiscott, J., Jefferies, W. A. (2005). Identification of Mechanisms Underlying Transporter Associated with Antigen Processing Deficiency in Metastatic Murine Carcinomas. Cancer Res. 65: 7485-7492 [Abstract] [Full Text]
Dupont, J., Latouche, J.-B., Ma, C., Sadelain, M. (2005). Artificial Antigen-Presenting Cells Transduced with Telomerase Efficiently Expand Epitope-Specific, Human Leukocyte Antigen-Restricted Cytotoxic T Cells. Cancer Res. 65: 5417-5427 [Abstract] [Full Text]
Alajez, N. M., Schmielau, J., Alter, M. D., Cascio, M., Finn, O. J. (2005). Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. Blood 105: 4583-4589 [Abstract] [Full Text]
Meissner, M., Reichert, T. E., Kunkel, M., Gooding, W., Whiteside, T. L., Ferrone, S., Seliger, B. (2005). Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome. Clin. Cancer Res. 11: 2552-2560 [Abstract] [Full Text]
Gonzalez, P. A., Carreno, L. J., Coombs, D., Mora, J. E., Palmieri, E., Goldstein, B., Nathenson, S. G., Kalergis, A. M. (2005). T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc. Natl. Acad. Sci. USA 102: 4824-4829 [Abstract] [Full Text]
Zhang, Q., Yang, X., Pins, M., Javonovic, B., Kuzel, T., Kim, S.-J., Parijs, L. V., Greenberg, N. M., Liu, V., Guo, Y., Lee, C. (2005). Adoptive Transfer of Tumor-Reactive Transforming Growth Factor-{beta}-Insensitive CD8+ T Cells: Eradication of Autologous Mouse Prostate Cancer. Cancer Res. 65: 1761-1769 [Abstract] [Full Text]
Chun, L., Yin, C.-C., Song, J.-Z., Liu, M.-X., Piao, J.-H., Lin, Q., Wang, X.-B., Huang, H.-L. (2004). Soluble Expression of Recombinant Human Secondary Lymphoid Chemokine (SLC) in E. coli and Research on Its In Vitro and In Vivo Bioactivity. J Biochem 136: 769-776 [Abstract] [Full Text]
Hillinger, S., Yang, S.-C., Zhu, L., Huang, M., Duckett, R., Atianzar, K., Batra, R. K., Strieter, R. M., Dubinett, S. M., Sharma, S. (2003). EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-{gamma}-Dependent Antitumor Responses in a Lung Cancer Model. J. Immunol. 171: 6457-6465 [Abstract] [Full Text]
Denkberg, G., Lev, A., Eisenbach, L., Benhar, I., Reiter, Y. (2003). Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen. J. Immunol. 171: 2197-2207 [Abstract] [Full Text]
Orengo, A. M., Di Carlo, E., Comes, A., Fabbi, M., Piazza, T., Cilli, M., Musiani, P., Ferrini, S. (2003). Tumor Cells Engineered with IL-12 and IL-15 Genes Induce Protective Antibody Responses in Nude Mice. J. Immunol. 171: 569-575 [Abstract] [Full Text]
Parkhurst, M. R., DePan, C., Riley, J. P., Rosenberg, S. A., Shu, S. (2003). Hybrids of Dendritic Cells and Tumor Cells Generated by Electrofusion Simultaneously Present Immunodominant Epitopes from Multiple Human Tumor-Associated Antigens in the Context of MHC Class I and Class II Molecules. J. Immunol. 170: 5317-5325 [Abstract] [Full Text]
Seliger, B., Atkins, D., Bock, M., Ritz, U., Ferrone, S., Huber, C., Storkel, S. (2003). Characterization of Human Lymphocyte Antigen Class I Antigen-processing Machinery Defects in Renal Cell Carcinoma Lesions with Special Emphasis on Transporter-associated with Antigen-processing Down-Regulation. Clin. Cancer Res. 9: 1721-1727 [Abstract] [Full Text]
Hodge, J. W., Grosenbach, D. W., Aarts, W. M., Poole, D. J., Schlom, J. (2003). Vaccine Therapy of Established Tumors in the Absence of Autoimmunity. Clin. Cancer Res. 9: 1837-1849 [Abstract] [Full Text]
Touloukian, C. E., Leitner, W. W., Schnur, R. E., Robbins, P. F., Li, Y., Southwood, S., Sette, A., Rosenberg, S. A., Restifo, N. P. (2003). Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1. J. Immunol. 170: 1579-1585 [Abstract] [Full Text]
Denkberg, G., Cohen, C. J., Lev, A., Chames, P., Hoogenboom, H. R., Reiter, Y. (2002). Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Proc. Natl. Acad. Sci. USA 99: 9421-9426 [Abstract] [Full Text]
Igney, F. H., Krammer, P. H. (2002). Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71: 907-920 [Abstract] [Full Text]
Guo, Y., Yang, T., Liu, X., Lu, S., Wen, J., Durbin, J. E., Liu, Y., Zheng, P. (2002). Cis elements for transporter associated with antigen-processing-2 transcription: two new promoters and an essential role of the IFN response factor binding element in IFN-{gamma}-mediated activation of the transcription initiator. Int Immunol 14: 189-200 [Abstract] [Full Text]
Lankat-Buttgereit, B., Tampe, R. (2002). The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases. Physiol. Rev. 82: 187-204 [Abstract] [Full Text]
Bullock, T. N. J., Mullins, D. W., Colella, T. A., Engelhard, V. H. (2001). Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice. J. Immunol. 167: 5824-5831 [Abstract] [Full Text]
Evans, M., Borysiewicz, L. K., Evans, A. S., Rowe, M., Jones, M., Gileadi, U., Cerundolo, V., Man, S. (2001). Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E6. J. Immunol. 167: 5420-5428 [Abstract] [Full Text]
Sharma, S., Stolina, M., Zhu, L., Lin, Y., Batra, R., Huang, M., Strieter, R., Dubinett, S. M. (2001). Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma. Cancer Res. 61: 6406-6412 [Abstract] [Full Text]
Grosenbach, D. W., Barrientos, J. C., Schlom, J., Hodge, J. W. (2001). Synergy of Vaccine Strategies to Amplify Antigen-specific Immune Responses and Antitumor Effects. Cancer Res. 61: 4497-4505 [Abstract] [Full Text]
Norbury, C. C., Princiotta, M. F., Bacik, I., Brutkiewicz, R. R., Wood, P., Elliott, T., Bennink, J. R., Yewdell, J. W. (2001). Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo. J. Immunol. 166: 4355-4362 [Abstract] [Full Text]
Sherritt, M., Cooper, L., Moss, D. J., Kienzle, N., Altman, J., Khanna, R. (2001). Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters. Int Immunol 13: 265-271 [Abstract] [Full Text]
Seliger, B., Wollscheid, U., Momburg, F., Blankenstein, T., Huber, C. (2001). Characterization of the Major Histocompatibility Complex Class I Deficiencies in B16 Melanoma Cells. Cancer Res. 61: 1095-1099 [Abstract] [Full Text]
Takahashi, A., Kono, K., Amemiya, H., Iizuka, H., Fujii, H., Matsumoto, Y. (2001). Elevated Caspase-3 Activity in Peripheral Blood T Cells Coexists with Increased Degree of T-Cell Apoptosis and Down-Regulation of TCR Zeta Molecules in Patients with Gastric Cancer. Clin. Cancer Res. 7: 74-80 [Abstract] [Full Text]
Dovhey, S. E., Ghosh, N. S., Wright, K. L. (2000). Loss of Interferon-{{gamma}} Inducibility of TAP1 and LMP2 in a Renal Cell Carcinoma Cell Line. Cancer Res. 60: 5789-5796 [Abstract] [Full Text]
Di Carlo, E., Comes, A., Basso, S., De Ambrosis, A., Meazza, R., Musiani, P., Moelling, K., Albini, A., Ferrini, S. (2000). The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement. J. Immunol. 165: 3111-3118 [Abstract] [Full Text]
Vanaja, D. K., Grossmann, M. E., Celis, E., Young, C. Y. F. (2000). Tumor Prevention and Antitumor Immunity with Heat Shock Protein 70 Induced by 15-Deoxy-{{Delta}}12,14-prostaglandin J2 in Transgenic Adenocarcinoma of Mouse Prostate Cells. Cancer Res. 60: 4714-4718 [Abstract] [Full Text]
Chen, J.-L., Dunbar, P. R., Gileadi, U., Jager, E., Gnjatic, S., Nagata, Y., Stockert, E., Panicali, D. L., Chen, Y.-T., Knuth, A., Old, L. J., Cerundolo, V. (2000). Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL. J. Immunol. 165: 948-955 [Abstract] [Full Text]
Nguyen, H. H., van Ginkel, F. W., Vu, H. L., Novak, M. J., McGhee, J. R., Mestecky, J. (2000). Gamma Interferon Is Not Required for Mucosal Cytotoxic T-Lymphocyte Responses or Heterosubtypic Immunity to Influenza A Virus Infection in Mice. J. Virol. 74: 5495-5501 [Abstract] [Full Text]
Dubinett, S. M., Batra, R. K., Miller, P. W., Sharma, S. (2000). Tumor Antigens in Thoracic Malignancy. Am. J. Respir. Cell Mol. Bio. 22: 524-527 [Full Text]
Zhang, Q.-J., Chen, S. S., Saari, C.-A., Massuci, M. G., Tufaro, F., Jefferies, W. A. (2000). Evidence of Selective Processing of Immunodominant Epitopes in Virally Infected Cells. J. Immunol. 164: 4513-4521 [Abstract] [Full Text]
Sharma, S., Stolina, M., Luo, J., Strieter, R. M., Burdick, M., Zhu, L. X., Batra, R. K., Dubinett, S. M. (2000). Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo. J. Immunol. 164: 4558-4563 [Abstract] [Full Text]
Sijts, A. J.A.M., Ruppert, T., Rehermann, B., Schmidt, M., Koszinowski, U., Kloetzel, P.-M. (2000). Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes. JEM 191: 503-514 [Abstract] [Full Text]
Lodge, P. A., Jones, L. A., Bader, R. A., Murphy, G. P., Salgaller, M. L. (2000). Dendritic Cell-based Immunotherapy of Prostate Cancer: Immune Monitoring of a Phase II Clinical Trial. Cancer Res. 60: 829-833 [Abstract] [Full Text]
Glas, R., Franksson, L., Une, C., Eloranta, M.-L., Ohlen, C., Orn, A., Karre, K. (2000). Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype: An Adaptive Component of Nk Cell-Mediated Responses. JEM 191: 129-138 [Abstract] [Full Text]
Johnsen, A. K., Templeton, D. J., Sy, M.-S., Harding, C. V. (1999). Deficiency of Transporter for Antigen Presentation (TAP) in Tumor Cells Allows Evasion of Immune Surveillance and Increases Tumorigenesis. J. Immunol. 163: 4224-4231 [Abstract] [Full Text]
Yamazaki, K., Spruill, G., Rhoderick, J., Spielman, J., Savaraj, N., Podack, E. R. (1999). Small Cell Lung Carcinomas Express Shared and Private Tumor Antigens Presented by HLA-A1 or HLA-A2. Cancer Res. 59: 4642-4650 [Abstract] [Full Text]
Zheng, P., Sarma, S., Guo, Y., Liu, Y. (1999). Two Mechanisms for Tumor Evasion of Preexisting Cytotoxic T-Cell Responses: Lessons from Recurrent Tumors. Cancer Res. 59: 3461-3467 [Abstract] [Full Text]
Martin, B. K., Frelinger, J. G., Ting, J. P.-Y. (1999). Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth. J. Immunol. 162: 6663-6670 [Abstract] [Full Text]
Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., Restifo, N. P. (1999). Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation. J. Immunol. 162: 5728-5737 [Abstract] [Full Text]
Marzo, A. L., Lake, R. A., Lo, D., Sherman, L., McWilliam, A., Nelson, D., Robinson, B. W. S., Scott, B. (1999). Tumor Antigens are Constitutively Presented in the Draining Lymph Nodes. J. Immunol. 162: 5838-5845 [Abstract] [Full Text]
Hiraki, A., Kaneshige, T., Kiura, K., Ueoka, H., Yamane, H., Tanaka, M., Harada, M. (1999). Loss of HLA Haplotype in Lung Cancer Cell Lines: Implications for Immunosurveillance of Altered HLA Class I/II Phenotypes in Lung Cancer. Clin. Cancer Res. 5: 933-936 [Abstract] [Full Text]
WEYNANTS, P., THONNARD, J., MARCHAND, M., DELOS, M., BOON, T., COULIE, P.�G. (1999). Derivation of Tumor-specific Cytolytic T-Cell Clones from Two Lung Cancer Patients with Long Survival. Am. J. Respir. Crit. Care Med. 159: 55-62 [Abstract] [Full Text]
Petersson, M., Charo, J., Salazar-Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T., Kiessling, R. (1998). Constitutive IL-10 Production Accounts for the High NK Sensitivity, Low MHC Class I Expression, and Poor Transporter Associated with Antigen Processing (TAP)-1/2 Function in the Prototype NK Target YAC-1. J. Immunol. 161: 2099-2105 [Abstract] [Full Text]
Lee, S. P., Constandinou, C. M., Thomas, W. A., Croom-Carter, D., Blake, N. W., Murray, P. G., Crocker, J., Rickinson, A. B. (1998). Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition. Blood 92: 1020-1030 [Abstract] [Full Text]
Fromm, S. V., Mey-Tal, S. W., Coligan, J. E., Schechter, C., Ehrlich, R. (1998). MHC Class I Heavy Chain mRNA Must Exceed a Threshold Level for the Reconstitution of Cell Surface Expression of Class I MHC Complexes in Cells Transformed by the Highly Oncogenic Adenovirus 12. J. Biol. Chem. 273: 15209-15216 [Abstract] [Full Text]
Bakker, A. B. H., Phillips, J. H., Figdor, C. G., Lanier, L. L. (1998). Killer Cell Inhibitory Receptors for MHC Class I Molecules Regulate Lysis of Melanoma Cells Mediated by NK cells, {gamma}{delta} T Cells, and Antigen-Specific CTL. J. Immunol. 160: 5239-5245 [Abstract] [Full Text]
Frisan, T., Levitsky, V., Polack, A., Masucci, M. G. (1998). Phenotype-Dependent Differences in Proteasome Subunit Composition and Cleavage Specificity in B Cell Lines. J. Immunol. 160: 3281-3289 [Abstract] [Full Text]
Shields, M. J., Assefi, N., Hodgson, W., Kim, E. J., Ribaudo, R. K. (1998). Characterization of the Interactions Between MHC Class I Subunits: A Systematic Approach for the Engineering of Higher Affinity Variants of {beta}2-Microglobulin. J. Immunol. 160: 2297-2307 [Abstract] [Full Text]
Wolpert, E. Z., Petersson, M., Chambers, B. J., Sandberg, J. K., Kiessling, R., Ljunggren, H.-G., Karre, K. (1997). Generation of CD8+ T cells specific for transporter associated with antigen processing deficient�cells. Proc. Natl. Acad. Sci. USA 94: 11496-11501 [Abstract] [Full Text]
Sing, A. P., Ambinder, R. F., Hong, D. J., Jensen, M., Batten, W., Petersdorf, E., Greenberg, P. D. (1997). Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease. Blood 89: 1978-1986 [Abstract] [Full Text]
Mey-Tal, S. V., Schechter, C., Ehrlich, R. (1997). Synthesis and Turnover of beta 2-Microglobulin in Ad12-transformed Cells Defective in Assembly and Transport of Class I Major Histocompatibility Complex Molecules. J. Biol. Chem. 272: 353-361 [Abstract] [Full Text]
Guo, Y, Wu, M, Chen, H, Wang, X, Liu, G, Li, G, Ma, J, Sy, M. (1994). Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263: 518-520 [Abstract]
Asavaroengchai, W., Kotera, Y., Mule, J. J. (2002). Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery. Proc. Natl. Acad. Sci. USA 99: 931-936 [Abstract] [Full Text]